Is a serum testosterone level of 9 ng/dL (or nmol/L) in a healthy 25‑year‑old woman normal, and does it require treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Testosterone Level of 9 ng/dL in a 25-Year-Old Woman

A serum testosterone of 9 ng/dL in a healthy 25-year-old woman is extremely low and requires immediate diagnostic workup to identify the underlying cause, though treatment decisions depend on whether she has symptoms of androgen deficiency.

Understanding Normal Female Testosterone Ranges

  • The normal reference range for total testosterone in reproductive-age women is approximately 14–28 ng/dL (mean ± 2 standard deviations), based on women without clinical signs of hyperandrogenism or menstrual dysfunction 1
  • A level of 9 ng/dL is markedly below the expected mean of 14.1 ng/dL and falls well outside the normal range for healthy premenopausal women 1
  • Commercial laboratory reference ranges often report upper limits as high as 95 ng/dL, which are clinically inappropriate and fail to detect true abnormalities in female testosterone levels 1

Clinical Significance of Low Testosterone in Young Women

  • Low testosterone in premenopausal women can indicate ovarian or adrenal insufficiency, hypopituitarism, or premature ovarian failure—all conditions requiring urgent evaluation 2
  • The distinction between primary (ovarian) and secondary (hypothalamic-pituitary) hypogonadism is critical, as it directs both diagnostic workup and treatment approach 2, 3

Essential Diagnostic Workup

Confirm the Diagnosis

  • Repeat morning total testosterone measurement (8–10 AM) on at least one additional occasion to confirm persistent low levels, as single measurements are unreliable due to assay variability 2, 3, 4
  • Ensure the laboratory uses a highly accurate assay (LC-MS/MS certified by the CDC Hormone Standardization Program) rather than direct immunoassays, which have significant variability 5, 6

Differentiate Primary from Secondary Hypogonadism

  • Measure serum LH and FSH after confirming low testosterone 2, 3
    • Elevated LH/FSH with low testosterone indicates primary ovarian failure
    • Low or inappropriately normal LH/FSH with low testosterone indicates secondary (hypothalamic-pituitary) hypogonadism 2, 3
  • Measure serum prolactin in all patients with low testosterone and low/normal gonadotropins to screen for hyperprolactinemia and pituitary adenomas 2, 3

Additional Essential Tests

  • Measure DHEA-S to assess adrenal androgen production, as low levels suggest adrenal insufficiency 2
  • Obtain fasting glucose and HbA1c to evaluate for metabolic conditions 2, 3
  • Check thyroid function (TSH) to exclude thyroid dysfunction that can affect reproductive hormones 2
  • Measure estradiol to assess overall ovarian function 2

Pituitary Imaging When Indicated

  • Order pituitary MRI if LH and FSH are low or inappropriately normal, prolactin is elevated (>1.5× upper limit of normal), or if there are visual field defects or other neurologic symptoms 2, 3

Treatment Considerations

For Premenopausal Women with Hypogonadism

  • The American College of Obstetricians and Gynecologists recommends estrogen replacement with progesterone as first-line therapy for premenopausal women with hypogonadism 2
  • Hormone therapy should be tailored based on whether hypogonadism occurred before or after puberty 2
  • Treatment decisions depend on the underlying cause (primary vs. secondary), presence of symptoms, and fertility goals 2, 3

Testosterone Replacement in Women

  • While testosterone therapy is used off-label in postmenopausal women with sexual dysfunction, there is limited evidence for testosterone replacement in premenopausal women with low testosterone 2
  • The primary focus should be on identifying and treating the underlying cause rather than empiric testosterone supplementation 2, 3

Critical Pitfalls to Avoid

  • Do not dismiss a low testosterone level as "normal variation" in a young woman—this degree of deficiency warrants investigation 1
  • Do not rely on a single testosterone measurement; require two separate morning values to confirm the diagnosis 2, 3, 4
  • Do not omit LH/FSH testing after confirming low testosterone, as the distinction between primary and secondary hypogonadism directs both diagnostic evaluation and treatment 2, 3
  • Do not use commercial laboratory reference ranges uncritically, as they often fail to detect clinically significant abnormalities in female testosterone levels 1
  • Do not initiate treatment without first identifying the underlying cause, as premature ovarian failure, pituitary disease, and adrenal insufficiency each require specific management 2, 3

Diagnostic Algorithm Summary

  1. Repeat morning total testosterone (8–10 AM) using LC-MS/MS assay 2, 3, 5
  2. If confirmed low (<14 ng/dL), measure LH, FSH, prolactin, DHEA-S, estradiol, TSH, and fasting glucose 2, 3
  3. If LH/FSH are low or normal with low testosterone, obtain pituitary MRI 2, 3
  4. Refer to endocrinology for management of confirmed hypogonadism 2
  5. Initiate hormone replacement therapy appropriate to the underlying diagnosis (estrogen/progesterone for ovarian failure, treatment of pituitary disease if present) 2

References

Research

Serum testosterone levels and reference ranges in reproductive-age women.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 1999

Guideline

Testosterone Injection Treatment for Male Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Hypogonadism in Young Adult Men

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Testosterone Grey Zone Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Standardization of testosterone measurements in humans.

The Journal of steroid biochemistry and molecular biology, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.